InvestorsHub Logo
Followers 120
Posts 20832
Boards Moderated 0
Alias Born 06/13/2011

Re: Pharmacydude post# 408707

Wednesday, 05/10/2023 7:23:27 PM

Wednesday, May 10, 2023 7:23:27 PM

Post# of 427301
Pdude. we can respectfully disagree .
Dr Bhatt IMHO involvement in MITIGATE was not because it was largely a Covid trial . Name another Covid trial he was part of. His interest IMHO is largely the exploratory CV endpoints ....which he knows , if the trial is / was run long enough ...can independently confirm to some degree the US-R-IT portion of his Reduce It trial .
Until we get some degree of independent confirm of some of the R-IT results ...Vascepa scripts both brand and generic go sideways at best in the US .
Vazkepa in the UK and EU will be a losing proposition ( costs will exceed income ) .
JMO
Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News